Study Summary
This trial will use two different types of incentive-based interventions to increase physical activity among low-income, mostly minority families in community settings.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: Months 1-18
Months 1-12
Change in mean daily step counts during the 12 month intervention
Change in mean minutes of moderate-to-vigorous physical activity (MVPA) during the 12 month intervention
Difference in proportion of weeks physical activity guidelines were achieved during the 12 month intervention
Months 1-18
Change in mean daily step counts during the 12 month intervention and 6 month follow up
Change in mean minutes of moderate-to-vigorous physical activity (MVPA) during the 12 month intervention and 6 month follow up
Difference in proportion of weeks physical activity guidelines were achieved during the 12 month intervention and 6 month follow up
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
Control
1 of 3
Social Incentive Gamification
1 of 3
Social Goals through Incentives to Charity
1 of 3
Active Control
Experimental Treatment
675 Total Participants · 3 Treatment Groups
Primary Treatment: Social Incentive Gamification · No Placebo Group · N/A
Social Incentive GamificationExperimental Group · 2 Interventions: Social Incentive Gamification, Daily Performance Feedback · Intervention Types: Behavioral, Behavioral
Social Goals through Incentives to CharityExperimental Group · 2 Interventions: Social Goals through Incentives to Charity, Daily Performance Feedback · Intervention Types: Behavioral, Behavioral
Control
Behavioral
ActiveComparator Group · 1 Intervention: Daily Performance Feedback · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social Incentive Gamification
2019
N/A
~180
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: months 1-18
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,588 Previous Clinical Trials
46,945,027 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
1,840 Previous Clinical Trials
41,125,707 Total Patients Enrolled
Karen Glanz, PhD, MPHPrincipal InvestigatorUniversity of Pennsylvania
8 Previous Clinical Trials
5,395 Total Patients Enrolled
Eligibility Criteria
Age Any Age · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are able to read and speak English.
You have a smartphone or tablet.\n
You are a member of a 2 to 10 member family team with at least one member 60 years or older.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments